← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Wake Forest University Health Sciences
Winston-Salem, NC
$3,013,075,485
Total funding
2,549
Grants
Funding over time
peak $192.5M · FY2005–25$200M$150M$100M$50M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,775,482,390 · 2405
DOD$245,468,361 · 119
CDC$19,490,792 · 14
AHRQ$4,049,908 · 8
NASA$3,615,042 · 7
DOE$949,469 · 1
FDA$311,024 · 1
USDA$310,382 · 2
By mechanism
R01$1,382,976,501 · 728
U01$253,649,862 · 57
—$250,343,254 · 129
N01$169,473,201 · 21
P01$118,124,441 · 131
P30$93,766,970 · 168
Investigators at Wake Forest University Health Sciences
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Largest grants
ARMED FORCES INSTITUTE OF REGENERATIVE MEDICINE$61,662,143
· FY2008 · Department of Defense
AFIRM II (ARMED FORCES INSTITUTE OF REGENERATIVE MEDICINE) CONSORTIUM. THIS AWARD IS FOR THE GENITOURINARY/LOWER ABDOMEN RECONSTRUCTION (GU) FOCUS A$19,002,641
· FY2013 · Defense Health Agency
Type 1 Diabetes Genetics Consortium$16,700,964
U01 · FY2005 · DK
AFIRM II CF$15,167,764
· FY2014 · Defense Health Agency
ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES FOLLOW-ON (ACCORDION) STUDY- C$15,053,808
N01 · FY2011 · HL
AFIRM II ER FOCUS AREA$14,431,744
· FY2014 · Defense Health Agency
SKIN REGENERATION$14,295,092
· FY2013 · Department of the Army
Limited Competition for the Continuation of the SEARCH for Diabetes in Youth Cohort Study (UC4)SEARCH for Diabetes in Youth Cohort Study$13,999,045
UC4 · FY2015 · DK
SPRINT$13,711,469
N01 · FY2010 · HL
COMPOSITE TISSUE ALLOTRANSPLANTATION AND IMMUNOMODULATION$13,510,105
· FY2013 · Defense Health Agency
Type 1 Diabetes Genetics Consortium$13,000,000
U01 · FY2004 · DK
MULTICENTER CLINICAL TRIAL OF KERATIN BIOMATERIALS FOR PERIPHERAL NERVE REGENERATION$10,687,389
· FY2010 · Department of the Army
LONG-TERM FOLLOW-UP OF THE DELAYED EFFECTS OF ACUTE RADIATION EXPOSURE IN PRIMATES$9,999,998
· FY2015 · Department of the Army
SPRINT$9,790,000
N01 · FY2009 · HL
ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES FOLLOW-ON (ACCORDION) STUDY- C$9,065,440
N01 · FY2014 · HL
Type 1 Diabetes Genetics Consortium$8,958,898
U01 · FY2003 · DK
BIOMEDICAL (BASIC)$8,511,177
N01 · FY2010 · HL
Therapeutic Effect of Intranasal Insulin on Cognition, Function, and AD Biomarker$8,033,304
RF1 · FY2012 · AG
Wake Forest Preclinical Imaging and Irradiation Facility$7,335,679
C06 · FY2020 · OD
Physical Rehabilitation for Older Patients with Acute HFpEF-The REHAB-HFpEF Trial$7,010,229
R01 · FY2023 · AG